See more : G&P Acquisition Corp. (GAPA) Income Statement Analysis – Financial Results
Complete financial analysis of Colgate-Palmolive Company (CL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Colgate-Palmolive Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
You may be interested
- Vodafone Group Public Limited Company (VODI.DE) Income Statement Analysis – Financial Results
- Haymaker Acquisition Corp. III (HYAC) Income Statement Analysis – Financial Results
- Greene Concepts, Inc. (INKW) Income Statement Analysis – Financial Results
- True North Commercial Real Estate Investment Trust (TUERF) Income Statement Analysis – Financial Results
- ID Holdings Corporation (4709.T) Income Statement Analysis – Financial Results
Colgate-Palmolive Company (CL)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.colgatepalmolive.com
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.46B | 17.97B | 17.42B | 16.47B | 15.69B | 15.54B | 15.45B | 15.20B | 16.03B | 17.28B | 17.42B | 17.09B | 16.73B | 15.56B | 15.33B | 15.33B | 13.79B | 12.24B | 11.40B | 10.58B | 9.90B | 9.29B | 9.43B | 9.36B | 9.12B | 8.97B | 9.06B | 8.75B | 8.36B | 7.59B | 7.14B | 7.01B | 6.06B | 5.69B | 5.04B | 4.73B | 5.65B | 4.98B | 4.52B |
| Cost of Revenue | 8.21B | 7.72B | 7.05B | 6.45B | 6.37B | 6.31B | 6.17B | 6.07B | 6.64B | 7.17B | 7.22B | 7.15B | 7.14B | 6.36B | 6.32B | 6.70B | 6.04B | 5.54B | 5.19B | 4.75B | 4.46B | 4.22B | 4.24B | 4.27B | 3.88B | 3.96B | 4.14B | 4.13B | 4.05B | 3.68B | 3.52B | 3.52B | 3.15B | 2.99B | 2.75B | 2.64B | 3.07B | 2.80B | 2.61B |
| Gross Profit | 11.25B | 10.25B | 10.38B | 10.02B | 9.33B | 9.23B | 9.28B | 9.12B | 9.40B | 10.11B | 10.20B | 9.93B | 9.59B | 9.20B | 9.01B | 8.63B | 7.75B | 6.70B | 6.21B | 5.84B | 5.45B | 5.07B | 5.19B | 5.09B | 5.23B | 5.01B | 4.92B | 4.61B | 4.31B | 3.91B | 3.62B | 3.49B | 2.91B | 2.70B | 2.29B | 2.09B | 2.58B | 2.18B | 1.92B |
| Gross Profit Ratio | 57.82% | 57.04% | 59.55% | 60.82% | 59.42% | 59.39% | 60.05% | 60.04% | 58.62% | 58.51% | 58.56% | 58.13% | 57.31% | 59.14% | 58.77% | 56.27% | 56.18% | 54.76% | 54.44% | 55.15% | 55.00% | 54.55% | 55.06% | 54.42% | 57.41% | 55.86% | 54.27% | 52.74% | 51.51% | 51.53% | 50.71% | 49.82% | 48.02% | 47.38% | 45.50% | 44.17% | 45.68% | 43.77% | 42.34% |
| Research & Development | 343.00M | 320.00M | 307.00M | 290.00M | 281.00M | 277.00M | 285.00M | 289.00M | 274.00M | 277.00M | 267.00M | 259.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 229.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.87B | 4.57B | 4.41B | 4.07B | 3.88B | 5.39B | 5.50B | 5.25B | 5.46B | 5.98B | 6.22B | 5.93B | 5.76B | 5.41B | 5.28B | 5.42B | 4.97B | 4.36B | 3.92B | 2.33B | 3.30B | 3.03B | 3.26B | 3.30B | 3.25B | 3.20B | 3.24B | 3.05B | 2.88B | 2.63B | 2.46B | 2.50B | 2.48B | 2.02B | 1.76B | 1.65B | 2.09B | 1.76B | 1.57B |
| Selling & Marketing | 2.37B | 2.00B | 2.00B | 1.95B | 1.69B | 1.59B | 1.57B | 1.43B | 1.49B | 1.78B | 1.89B | 1.79B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.06B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.24B | 6.57B | 6.41B | 6.02B | 5.58B | 5.39B | 5.50B | 5.25B | 5.46B | 5.98B | 6.22B | 5.93B | 5.76B | 5.41B | 5.28B | 5.42B | 4.97B | 4.36B | 3.92B | 3.40B | 3.30B | 3.03B | 3.26B | 3.30B | 3.25B | 3.20B | 3.24B | 3.05B | 2.88B | 2.63B | 2.46B | 2.50B | 2.48B | 2.02B | 1.76B | 1.65B | 2.09B | 1.76B | 1.57B |
| Other Expenses | 0.00 | 69.00M | 65.00M | 113.00M | 196.00M | -87.00M | 36.00M | 22.00M | 39.00M | 14.00M | 27.00M | 30.00M | -9.00M | 301.00M | 111.00M | 183.40M | 65.70M | 32.80M | 69.20M | 22.20M | -74.30M | 23.00M | 68.00M | 72.10M | 340.20M | 330.30M | 319.90M | 316.30M | 300.30M | 235.10M | 209.60M | 192.50M | 146.20M | 126.20M | 97.00M | 82.00M | 101.30M | 89.30M | 72.20M |
| Operating Expenses | 7.34B | 6.63B | 6.47B | 6.13B | 5.77B | 5.54B | 5.69B | 5.27B | 5.53B | 6.55B | 6.65B | 6.04B | 5.75B | 5.41B | 5.39B | 5.61B | 5.04B | 4.39B | 3.99B | 3.65B | 3.22B | 3.06B | 3.33B | 3.37B | 3.59B | 3.53B | 3.56B | 3.37B | 3.18B | 2.86B | 2.67B | 2.69B | 2.63B | 2.14B | 1.86B | 1.73B | 2.20B | 1.85B | 1.64B |
| Cost & Expenses | 15.47B | 14.35B | 13.52B | 12.59B | 12.14B | 11.85B | 11.87B | 11.34B | 12.16B | 13.72B | 13.86B | 13.20B | 12.89B | 11.77B | 11.71B | 12.31B | 11.08B | 9.92B | 9.18B | 8.39B | 7.68B | 7.28B | 7.57B | 7.64B | 7.48B | 7.49B | 7.70B | 7.50B | 7.23B | 6.54B | 6.19B | 6.21B | 5.78B | 5.14B | 4.60B | 4.37B | 5.26B | 4.65B | 4.25B |
| Interest Income | 55.00M | 14.00M | 17.00M | 19.00M | 47.00M | 50.00M | 51.00M | 50.00M | 107.00M | 106.00M | 125.00M | 65.00M | 7.00M | 6.00M | 11.00M | 10.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 287.00M | 167.00M | 192.00M | 183.00M | 192.00M | 193.00M | 153.00M | 149.00M | 133.00M | 130.00M | 116.00M | 80.00M | 59.00M | 59.00M | 77.00M | 105.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.02B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 567.00M | 545.00M | 556.00M | 539.00M | 519.00M | 511.00M | 475.00M | 443.00M | 449.00M | 442.00M | 439.00M | 425.00M | 421.00M | 376.00M | 351.00M | 347.60M | 333.90M | 328.70M | 329.30M | 327.80M | 315.50M | 296.50M | 336.20M | 337.80M | 340.20M | 330.30M | 319.90M | 316.30M | 300.30M | 235.10M | 209.60M | 192.50M | 146.20M | 126.20M | 97.00M | 82.00M | 101.30M | 89.30M | 72.20M |
| EBITDA | 4.25B | 4.13B | 4.37B | 4.33B | 4.16B | 4.17B | 4.12B | 4.33B | 3.35B | 4.11B | 4.12B | 4.38B | 4.27B | 3.87B | 3.98B | 3.46B | 3.06B | 2.55B | 2.61B | 2.50B | 2.47B | 2.31B | 2.17B | 2.08B | 1.98B | 1.81B | 1.68B | 1.56B | 1.43B | 1.28B | 1.16B | 991.10M | 427.80M | 680.90M | 532.40M | 445.50M | 485.30M | 421.60M | 349.00M |
| EBITDA Ratio | 21.82% | 27.16% | 28.87% | 26.86% | 25.95% | 27.05% | 26.30% | 28.66% | 33.72% | 23.15% | 22.93% | 25.25% | 25.47% | 26.77% | 25.88% | 21.97% | 22.35% | 22.54% | 22.93% | 24.14% | 24.93% | 24.52% | 23.17% | 21.46% | 22.52% | 20.24% | 18.80% | 18.93% | 23.35% | 18.02% | 17.30% | 14.44% | 6.49% | 11.92% | 8.62% | 9.55% | 11.64% | 7.64% | 6.55% |
| Operating Income | 3.98B | 4.34B | 4.47B | 3.89B | 3.55B | 3.69B | 3.59B | 3.84B | 2.79B | 3.56B | 3.56B | 3.89B | 3.84B | 3.79B | 3.62B | 3.02B | 2.65B | 2.16B | 2.22B | 2.12B | 2.17B | 2.01B | 1.86B | 1.72B | 1.64B | 1.48B | 1.36B | 1.25B | 1.13B | 1.05B | 954.30M | 798.60M | 281.60M | 554.70M | 435.40M | 363.50M | 384.00M | 332.30M | 276.80M |
| Operating Income Ratio | 20.48% | 24.13% | 25.68% | 23.59% | 22.65% | 23.76% | 23.22% | 25.25% | 17.39% | 20.59% | 20.41% | 22.76% | 22.95% | 24.35% | 23.59% | 19.70% | 19.24% | 17.65% | 19.44% | 20.05% | 21.87% | 21.66% | 19.74% | 18.39% | 17.98% | 16.54% | 15.00% | 14.24% | 13.47% | 13.83% | 13.36% | 11.40% | 4.65% | 9.75% | 8.64% | 7.68% | 6.80% | 6.67% | 6.12% |
| Total Other Income/Expenses | -592.00M | -233.00M | -245.00M | -238.00M | -253.00M | -230.00M | -220.00M | -99.00M | -26.00M | -24.00M | 9.00M | -118.00M | -52.00M | -59.00M | -77.00M | -15.70M | -89.50M | -158.70M | -80.70M | -151.20M | -124.10M | -142.80M | -166.10M | -173.30M | -245.20M | -234.10M | -255.90M | -291.20M | -762.00M | -169.50M | -118.10M | -70.70M | -63.70M | -43.30M | 11.50M | -113.20M | -261.20M | -35.30M | -1.30M |
| Income Before Tax | 3.39B | 2.66B | 3.09B | 3.65B | 3.30B | 3.46B | 3.49B | 3.74B | 2.76B | 3.53B | 3.57B | 3.87B | 3.79B | 3.43B | 3.54B | 2.93B | 2.50B | 2.00B | 2.08B | 2.00B | 2.04B | 1.87B | 1.67B | 1.57B | 1.39B | 1.25B | 1.10B | 954.60M | 363.50M | 879.90M | 836.20M | 727.90M | 217.90M | 511.40M | 446.90M | 250.30M | 122.80M | 297.00M | 275.50M |
| Income Before Tax Ratio | 17.43% | 14.80% | 17.72% | 22.14% | 21.03% | 22.29% | 22.56% | 24.60% | 17.23% | 20.45% | 20.46% | 22.67% | 22.64% | 22.04% | 23.08% | 19.08% | 18.10% | 16.36% | 18.24% | 18.92% | 20.62% | 20.12% | 17.70% | 16.75% | 15.29% | 13.93% | 12.17% | 10.91% | 4.35% | 11.60% | 11.71% | 10.39% | 3.60% | 8.99% | 8.87% | 5.29% | 2.17% | 5.96% | 6.09% |
| Income Tax Expense | 937.00M | 693.00M | 749.00M | 787.00M | 774.00M | 906.00M | 1.31B | 1.15B | 1.22B | 1.19B | 1.16B | 1.24B | 1.24B | 1.12B | 1.14B | 967.90M | 759.10M | 648.40M | 727.60M | 675.30M | 620.60M | 582.00M | 522.10M | 503.40M | 457.30M | 401.50M | 361.90M | 319.60M | 191.50M | 299.70M | 288.10M | 250.90M | 93.00M | 190.40M | 166.90M | 97.60M | 68.80M | 119.50M | 107.70M |
| Net Income | 2.30B | 1.79B | 2.17B | 2.70B | 2.37B | 2.40B | 2.02B | 2.44B | 1.38B | 2.18B | 2.24B | 2.47B | 2.43B | 2.20B | 2.29B | 1.96B | 1.74B | 1.35B | 1.35B | 1.33B | 1.42B | 1.29B | 1.15B | 1.06B | 937.30M | 848.60M | 740.40M | 635.00M | 172.00M | 580.20M | 189.90M | 477.00M | 124.90M | 321.00M | 280.00M | 192.80M | 54.00M | 177.50M | 171.90M |
| Net Income Ratio | 11.82% | 9.93% | 12.43% | 16.36% | 15.08% | 15.44% | 13.10% | 16.06% | 8.63% | 12.62% | 12.86% | 14.47% | 14.53% | 14.15% | 14.95% | 12.77% | 12.60% | 11.06% | 11.86% | 12.54% | 14.35% | 13.86% | 12.16% | 11.37% | 10.28% | 9.46% | 8.18% | 7.26% | 2.06% | 7.65% | 2.66% | 6.81% | 2.06% | 5.64% | 5.56% | 4.07% | 0.96% | 3.56% | 3.80% |
| EPS | 2.78 | 2.13 | 2.56 | 3.15 | 2.76 | 2.76 | 2.30 | 2.74 | 1.53 | 2.38 | 2.41 | 2.60 | 2.49 | 2.23 | 2.27 | 1.91 | 1.68 | 1.29 | 1.27 | 1.23 | 1.30 | 1.17 | 1.01 | 0.91 | 0.79 | 0.70 | 0.61 | 0.53 | 0.13 | 0.48 | 0.14 | 0.37 | 0.10 | 0.28 | 0.25 | 0.18 | 0.05 | 0.16 | 0.14 |
| EPS Diluted | 2.77 | 2.13 | 2.55 | 3.14 | 2.75 | 2.75 | 2.28 | 2.72 | 1.52 | 2.36 | 2.38 | 2.58 | 2.47 | 2.15 | 2.19 | 1.83 | 1.60 | 1.23 | 1.22 | 1.17 | 1.23 | 1.10 | 0.95 | 0.85 | 0.74 | 0.65 | 0.56 | 0.49 | 0.13 | 0.45 | 0.13 | 0.35 | 0.10 | 0.27 | 0.24 | 0.18 | 0.05 | 0.16 | 0.14 |
| Weighted Avg Shares Out | 827.40M | 836.40M | 845.00M | 856.80M | 859.10M | 870.60M | 881.80M | 891.80M | 902.20M | 915.10M | 930.80M | 952.20M | 976.60M | 975.60M | 999.00M | 1.01B | 1.02B | 1.03B | 1.04B | 1.06B | 1.07B | 1.09B | 1.11B | 1.15B | 1.17B | 1.18B | 1.18B | 1.17B | 1.16B | 1.17B | 1.25B | 1.25B | 1.10B | 1.06B | 1.08B | 1.07B | 1.07B | 1.11B | 929.71M |
| Weighted Avg Shares Out (Dil) | 829.20M | 838.80M | 848.30M | 859.30M | 861.10M | 873.00M | 887.80M | 898.40M | 909.70M | 924.30M | 939.90M | 960.20M | 984.00M | 1.02B | 1.05B | 1.07B | 1.07B | 1.08B | 1.09B | 1.12B | 1.13B | 1.16B | 1.19B | 1.23B | 1.25B | 1.27B | 1.27B | 1.25B | 1.16B | 1.26B | 1.29B | 1.32B | 1.10B | 1.14B | 1.12B | 1.07B | 1.07B | 1.11B | 929.71M |
Why Colgate-Palmolive (CL) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Colgate Gains 21.3% YTD: What Makes the Stock Apt to Retain?
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Colgate-Palmolive Company (CL) Morgan Stanley Global Consumer & Retail Conference - (Transcript)
Colgate-Palmolive Company (NYSE:CL ) Morgan Stanley Global Consumer & Retail Conference Call December 3, 2024 11:45 AM ET Company Participants Stanley Sutula III - Chief Financial Officer Panagiotis Tsourapas - Group President, Europe and Developing Markets Conference Call Participants Dara...
My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys
Investment activity in October focused on Business Development Companies, with $1,300 added to the market. Adjusted dividend income in October of $789, up 25% Y/Y and up 11% sequentially. Main picks included Blackstone Secured Lending, Goldman Sachs BDC, and Midcap...
Colgate-Palmolive Webcasts Fireside Chat at the Morgan Stanley Global Consumer & Retail Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Group President, Europe and Developing Markets, Panagiotis Tsourapas and Chief Financial Officer, Stan Sutula, will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on Tuesday, December 3, 2024 at 11:45...
CL's Pricing & Productivity Efforts Bode Well: Apt to Hold the Stock?
Colgate benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Colgate Women's Games Officially Kicks off 49th Season with Return to Indoor Competition
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) announces today that registration for Colgate Women's Games, the nation's longest-running indoor Track & Field series for girls and women, is now open. Now through January 5, 2025, athletes can register online to compete and parents,...
3 Reasons Why Growth Investors Shouldn't Overlook Colgate-Palmolive (CL)
Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Consumer Staples Stocks Lagging ColgatePalmolive (CL) This Year?
Here is how Colgate-Palmolive (CL) and Lancaster Colony (LANC) have performed compared to their sector so far this year.
Cramer's Stop Trading: Colgate-Palmolive
CNBC's Jim Cramer explains why he is keeping an eye on shares of Colgate-Palmolive.
Source: https://incomestatements.info
Category: Stock Reports